Leadership Overview
Allucent has 5 executives leading key functions including strategy, information technology, marketing, product development, and clinical trial operations.
Focused on accelerating global drug development, Allucent delivers comprehensive research solutions through an individualized partnership model that brings novel treatments to patients across more than 60 countries.
Focused on accelerating global drug development, Allucent delivers comprehensive research solutions through an individualized partnership model that brings novel treatments to patients across more than 60 countries.
Leadership Roles at Allucent
Paula Stafford - Chief Executive Officer
Paula Stafford, the Chief Executive Officer at Allucent, directs the overarching corporate strategy and global vision for the organization. By aligning internal resources with the complex demands of drug development, the Chief Executive Officer ensures that the company maintains a competitive edge across diverse therapeutic areas. Stafford oversees the integration of various service providers into a unified, high-performance entity capable of navigating international regulatory landscapes. This leadership role involves constant collaboration with the Board to drive long-term growth and operational excellence. Through the implementation of individualized partnership models, Paula Stafford fosters deep client relationships that translate into successful clinical outcomes. Ultimately, the Chief Executive Officer secures the firm's position as a premier partner for pharmaceutical innovators seeking to deliver life-saving treatments to patients worldwide, while simultaneously managing the complexities of operations spanning over 60 countries.
Leslie Devos - President, Product Development Strategy
Leslie Devos, the President, Product Development Strategy at Allucent, architects the scientific frameworks and strategic roadmaps for client drug development programs. By providing experience-driven insights, the President, Product Development Strategy ensures that clinical pathways are optimized for success from early-stage research through regulatory approval. Devos oversees the design of complex development plans that address the unique needs of various therapeutic areas, ensuring alignment with global standards. This leadership role involves guiding cross-functional teams to navigate the intricacies of novel treatment delivery. Leslie Devos collaborates with the executive leadership to refine the company's service offerings, ensuring that the firm remains at the forefront of scientific innovation. By focusing on strategic planning and technical excellence, the President, Product Development Strategy directly impacts the speed and efficiency with which clients bring new therapies to patients, ultimately strengthening the company's reputation for high-quality research outcomes.

Anita Nelsen - President, Clinical Trial Operations
Anita Nelsen, the President, Clinical Trial Operations at Allucent, executes the day-to-day management of global clinical research activities. By overseeing the implementation of trial protocols across more than 60 countries, the President, Clinical Trial Operations ensures that all studies meet rigorous quality and compliance standards. Nelsen directs the operational teams responsible for site management, patient recruitment, and data collection, ensuring that every project remains on schedule and within scope. This leadership role involves constant coordination with internal departments to resolve logistical challenges and maintain high performance levels. Anita Nelsen drives the operational excellence required to support the company's mission of delivering novel treatments to patients in need. By optimizing resource allocation and streamlining trial processes, the President, Clinical Trial Operations facilitates the successful execution of complex research programs, directly contributing to the firm's ability to provide reliable, high-quality clinical development solutions to a global client base.
Nathan Thompson - Chief Information Officer
Nathan Thompson, the Chief Information Officer at Allucent, architects the digital infrastructure necessary to support global drug development operations. By deploying advanced data management systems, the Chief Information Officer ensures the security and integrity of clinical trial information across all 60 countries of operation. Thompson drives the digital transformation agenda, integrating cutting-edge technology into the company's research workflows to enhance efficiency and data-driven decision-making. This leadership role involves close coordination with the executive team to align technical capabilities with the broader business mission of delivering novel treatments. Nathan Thompson optimizes internal platforms to facilitate seamless collaboration between global teams and external partners. By prioritizing scalable cloud solutions and robust cybersecurity, the Chief Information Officer protects the intellectual property of clients while maintaining the high standards required for complex, multi-phase clinical research projects.

Steffany Cox - Chief Marketing Officer
Steffany Cox, the Chief Marketing Officer at Allucent, drives the global brand strategy and market positioning for the organization. By articulating the value of the company's comprehensive drug development solutions, the Chief Marketing Officer ensures that the firm remains the preferred partner for pharmaceutical innovators. Cox oversees all external communications, digital presence, and industry engagement initiatives to expand the company's footprint across diverse therapeutic markets. This leadership role involves crafting compelling narratives that highlight the firm's 30 years of experience and individualized partnership approach. Steffany Cox collaborates with the executive team to translate complex research capabilities into clear, actionable market insights that resonate with global clients. By analyzing market trends and competitive dynamics, the Chief Marketing Officer shapes the long-term growth trajectory of the business, ensuring that the brand effectively communicates the impact of its work on patient health outcomes.

Explore Leadership Teams in Business Services
INL is one of the U.S. Department of Energy's (DOE's) national laboratories. The laboratory performs work in each of DOE's strategic goal areas: energy, national security, science and environment. INL is the nation's center for nuclear energy research and development. The company is based in Idaho Falls, Idaho.
Company Leadership

WA
KL
Aragen Life Sciences is a company that specializes in research and development operations for pharma, biotech, agrochemical, and animal health companies among other industries. They are based in Hyderabad, India.
Company Leadership MK


The Urban Institute operates as a nonpartisan research organization committed to generating rigorous analysis and evidence-based insights on critical social and economic policy questions. Through empirical research and data-driven investigation, the organization works to inform public discourse and guide policymakers toward solutions that address complex societal challenges. The institute's work spans multiple dimensions of policy analysis, examining issues that directly affect communities and individuals across diverse socioeconomic circumstances. The organization maintains a multidisciplinary approach to research, bringing together economists, social scientists, and policy experts who collaborate to produce comprehensive studies and evaluations. This collaborative model enables the institute to examine interconnected policy challenges from multiple perspectives, generating nuanced findings that reflect the complexity of real-world problems. The research teams conduct original data collection, statistical analysis, and longitudinal studies designed to track outcomes and measure the effectiveness of various policy interventions. Urban Institute research addresses a broad spectrum of policy domains, including economic opportunity, education systems, health care access, housing markets, and government effectiveness.
Company Leadership JP

Founded in 1930, The Woods Hole Oceanographic Institution is a non-profit organization that supports marine research, engineering, and higher education. Woods Hole Oceanographic Institution is headquartered in Woods Hole, Massachusetts.
Company Leadership FS
KG
SH
